These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33668564)

  • 21. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
    Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
    Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot Study to Demonstrate Improvement in Skin Tone and Texture by Treatment with a 1064 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser.
    Munavalli GS; Leight-Dunn HM
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial Effect of Low Fluence 1,064 nm Q-Switched Neodymium:Yttrium-Aluminum-Garnet Laser in the Treatment of Senile Lentigo.
    Nam JH; Kim HS; Lee GY; Kim WS
    Ann Dermatol; 2017 Aug; 29(4):427-432. PubMed ID: 28761290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
    Lee Y; Choi EH; Lee SW
    Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective, randomized, double-blinded, split-face pilot study comparing Q-switched 1064-nm Nd:YAG versus 532-nm Nd:YAG laser for the treatment of solar lentigines.
    Bohnert K; Dorizas A; Sadick N
    J Cosmet Laser Ther; 2018; 20(7-8):395-397. PubMed ID: 29482397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Low Fluence Combination Laser Treatment of Solar Lentigines in Type III Asian Skin.
    Tian BW
    J Cutan Aesthet Surg; 2015; 8(4):230-2. PubMed ID: 26865789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between the use of intense pulsed light and Q-switched neodymium-doped yttrium aluminum garnet laser for the treatment of axillary hyperpigmentation.
    Amornpetkul W; Kanokrungsee S; Kamanamool N; Udompataikul M; Rojhirunsakool S
    J Cosmet Dermatol; 2021 Sep; 20(9):2785-2793. PubMed ID: 33550634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of treatment efficacy and the incidence of post-inflammatory hyperpigmentation with different degrees of irradiation using two different quality-switched lasers for removing solar lentigines on Asian skin.
    Negishi K; Akita H; Tanaka S; Yokoyama Y; Wakamatsu S; Matsunaga K
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):307-12. PubMed ID: 22181827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of facial and non-facial lentigines with a 730 nm picosecond titanium: Sapphire laser is safe and effective.
    Kauvar ANB; Sun R; Bhawan J; Singh G; Ugonabo N; Feng H; Schomacker K
    Lasers Surg Med; 2022 Jan; 54(1):89-97. PubMed ID: 34402537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Case of Facial Partial Unilateral Lentiginosis Treated with Low-Fluence 1,064 nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser.
    Kim EH
    Case Rep Dermatol; 2017; 9(2):30-34. PubMed ID: 28690515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial.
    Todd MM; Rallis TM; Gerwels JW; Hata TR
    Arch Dermatol; 2000 Jul; 136(7):841-6. PubMed ID: 10890985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the frequency-doubled Q-switched Nd:YAG laser and 35% trichloroacetic acid for the treatment of face lentigines.
    Li YT; Yang KC
    Dermatol Surg; 1999 Mar; 25(3):202-4. PubMed ID: 10193967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study.
    Tse Y; Levine VJ; McClain SA; Ashinoff R
    J Dermatol Surg Oncol; 1994 Dec; 20(12):795-800. PubMed ID: 7798410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized control study of the prevention of hyperpigmentation post Q-switched Nd:YAG laser treatment of Hori nevus using topical fucidic acid plus betamethasone valerate cream versus fucidic acid cream.
    Uaboonkul T; Nakakes A; Ayuthaya PK
    J Cosmet Laser Ther; 2012 Jun; 14(3):145-9. PubMed ID: 22471899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Q-switched Double-frequency 532-nm Neodymium-doped Yttrium Aluminum Garnet Laser in the Treatment of Lip Hyperpigmentation: A Pilot Study.
    Al-Haddab M; Alali A; Al-Otiabi H
    J Clin Aesthet Dermatol; 2021 Jul; 14(7):22-25. PubMed ID: 34840645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective analysis of the management of freckles and lentigines using four different pigment lasers on Asian skin.
    Ho SG; Chan NP; Yeung CK; Shek SY; Kono T; Chan HH
    J Cosmet Laser Ther; 2012 Apr; 14(2):74-80. PubMed ID: 22372516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of the 300 microsecond 1064 nm Nd:YAG laser in the treatment of keloids.
    Rossi A; Lu R; Frey MK; Kubota T; Smith LA; Perez M
    J Drugs Dermatol; 2013 Nov; 12(11):1256-62. PubMed ID: 24196333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brimonidine tartrate gel plus topical steroid for the prevention of laser therapy-related postinflammatory hyperpigmentation.
    Hong JY; Lee HW; Park KY; Kim BJ; Kim MN
    Dermatol Ther; 2018 Sep; 31(5):e12657. PubMed ID: 30028559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.